CDKN2A and melanoma: The presence of ulceration is an important prognostic factor for melanoma even in stage III or metastatic disease (Balch et al.,2001) and, therefore, we also assessed the associations between CDKN2A deletion and BRAF/NRAS mutation and ulceration.